8-(4-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)BUTYL)-2-HYDROXY-8-AZASPIRO(4.5)DECANE-7,9-DIONE
UNII AF6B335MDG
Substance Identification & Data
This profile provides standardized clinical and technical data for 8-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)-2-hydroxy-8-azaspiro(4.5)decane-7,9-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AF6B335MDG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 131779-32-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H32N4O3S OXWHAAOUFXSEQT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 8-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)-2-hydroxy-8-azaspiro(4.5)decane-7,9-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.